Glioblastoma cells were treated with a Notch-1 inhibitor (MRK-003) and resulted in a decrease of p53 restoration and significantly inhibition of p53 translocation to the nucleus, which indicates that Notch-1 activated is able to augment p53 expression and restore its function. Here, NOTCH1 is linked to glioblastoma.